1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.

Pharmaceutical study calls for ad ban

Discussion in 'Article Discussion' started by BlueMystic, Jul 25, 2005.

  1. BlueMystic

    BlueMystic Gold Member

    Reputation Points:
    Jan 28, 2005
    from The Netherlands

    Pharmaceutical study prompts call for ad ban

    ABC News Online
    July 17, 2005

    The authors of research into pharmaceutical marketing have called for a ban on drug company ads being inserted in doctors' prescribing software.

    A paper released in today's Medical Journal of Australia has raised concerns that the pharmaceutical industry spends up to three times as much on marketing as it does on research and development.

    The president of the Doctors' Reform Society, Dr Tim Woodruff, says the research reveals the pharmaceutical industry is consistently breaking its own code of conduct on marketing.

    Dr Woodruff says too many doctors are prescribing new and expensive drugs when cheaper alternatives are available, and this fuels the cost blow-out in the Pharmaceutical benefits Scheme.

    "Confronting every doctor when they're writing their prescription, they now have advertisements for various drugs," he said.

    "And the drug companies are not going to be doing this unless they think that it's going to influence the prescribing behaviour of doctors.

    "Doctors then tend to prescribe the most expensive, newest drugs."